1-hexadecyl-2-acetyl-glycero-3-phosphocholine and A-Thalassemia

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with A-Thalassemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chuansumrit, A; Kadegasem, P; Sirachainan, N; Sirivadhanakul, P; Songdej, D; Wongwerawattanakoon, P	1

Trials

1 trial(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and A-Thalassemia

Article	Year
Increased endothelial activation in α-thalassemia disease. Annals of hematology, 2019, Volume: 98, Issue:7 Topics: Adolescent; Adult; alpha-Thalassemia; Biomarkers; Blood Transfusion; Child; Child, Preschool; Endothelium, Vascular; Female; Ferritins; Humans; Infant; Iron Chelating Agents; Male; Platelet Activating Factor; Platelet Activation; Thrombomodulin; Thromboxane B2; Vascular Cell Adhesion Molecule-1; von Willebrand Factor	2019

Article

Year

Increased endothelial activation in α-thalassemia disease.

Annals of hematology, 2019, Volume: 98, Issue:7

Topics: Adolescent; Adult; alpha-Thalassemia; Biomarkers; Blood Transfusion; Child; Child, Preschool; Endothelium, Vascular; Female; Ferritins; Humans; Infant; Iron Chelating Agents; Male; Platelet Activating Factor; Platelet Activation; Thrombomodulin; Thromboxane B2; Vascular Cell Adhesion Molecule-1; von Willebrand Factor

2019